Last 12 months
Inside the activity.
6 purchase rows · 11 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 1 | 0 |
| Feb 2026 | 2 | 0 |
| Mar 2026 | 0 | 6 |
| Apr 2026 | 2 | 0 |
| May 2026 | 1 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 21, 2007 Filed Aug 23, 2007 17:10 UTC |
GONZALEZ RICHARD ADirector · President and COO
|
GrantOption (right to buy) · Derivative | 219,192 | $0.00 Strike: $52.39 | $0.00 |
DisclosureSEC source: 0001104659-07-064482 · a4.xml · derivative · entry 6 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 219,192 Underlying: common shares · 219,192 shares Expires 2013-02-13 F3 · security: Employee stock option including a replacement option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| August 21, 2007 Filed Aug 23, 2007 17:10 UTC |
GONZALEZ RICHARD ADirector · President and COO
|
Exercise / conversionOption (right to buy) · Derivative | 281,530 | $0.00 Strike: $33.23 | $0.00 |
DisclosureSEC source: 0001104659-07-064482 · a4.xml · derivative · entry 5 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,705 Underlying: common shares · 281,530 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option including a replacement option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| August 21, 2007 Filed Aug 23, 2007 17:10 UTC |
GONZALEZ RICHARD ADirector · President and COO
|
Tax withholdingCommon shares without par value | 219,192 | $52.39 | $11,483,468.88 |
DisclosureSEC source: 0001104659-07-064482 · a4.xml · nonDerivative · entry 2 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 469,758 Read SEC document |
| August 21, 2007 Filed Aug 23, 2007 17:10 UTC |
GONZALEZ RICHARD ADirector · President and COO
|
Exercise / conversionCommon shares without par value | 281,530 | $33.23 | $9,355,636.04 |
DisclosureSEC source: 0001104659-07-064482 · a4.xml · nonDerivative · entry 1 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 688,950 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 21, 2007 Filed Aug 23, 2007 21:10 UTC |
Fussell Stephen RSenior Vice President
|
GrantOption (right to buy) · Derivative | 15,116 | $0.00 Strike: $52.39 | $0.00 |
DisclosureSEC source: 0001104659-07-064609 · a4.xml · derivative · entry 5 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,116 Underlying: common shares · 15,116 shares Expires 2014-02-19 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| August 21, 2007 Filed Aug 23, 2007 21:10 UTC |
Fussell Stephen RSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 17,400 | $0.00 Strike: $41.03 | $0.00 |
DisclosureSEC source: 0001104659-07-064609 · a4.xml · derivative · entry 4 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,454 Underlying: common shares · 17,400 shares Expires 2014-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| August 21, 2007 Filed Aug 23, 2007 21:10 UTC |
Fussell Stephen RSenior Vice President
|
Tax withholdingCommon shares without par value | 15,116 | $52.39 | $791,927.24 |
DisclosureSEC source: 0001104659-07-064609 · a4.xml · nonDerivative · entry 2 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,666 Read SEC document |
| August 21, 2007 Filed Aug 23, 2007 21:10 UTC |
Fussell Stephen RSenior Vice President
|
Exercise / conversionCommon shares without par value | 17,400 | $41.03 | $713,951.58 |
DisclosureSEC source: 0001104659-07-064609 · a4.xml · nonDerivative · entry 1 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,782 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 20, 2007 Filed Aug 21, 2007 19:04 UTC |
Michael Edward L.Executive Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 2,875 | $0.00 Strike: $34.77 | $0.00 |
DisclosureSEC source: 0001104659-07-063971 · a4.xml · derivative · entry 3 Michael Edward L · CIK 0001391823 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 2,875 shares Expires 2008-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Employee stock option, including replacement option feature granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| August 20, 2007 Filed Aug 21, 2007 19:04 UTC |
Michael Edward L.Executive Vice President
|
Tax withholdingCommon shares without par value | 1,895 | $52.73 | $99,923.35 |
DisclosureSEC source: 0001104659-07-063971 · a4.xml · nonDerivative · entry 2 Michael Edward L · CIK 0001391823 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,311 Read SEC document |
| August 20, 2007 Filed Aug 21, 2007 19:04 UTC |
Michael Edward L.Executive Vice President
|
Exercise / conversionCommon shares without par value | 2,875 | $34.77 | $99,971.51 |
DisclosureSEC source: 0001104659-07-063971 · a4.xml · nonDerivative · entry 1 Michael Edward L · CIK 0001391823 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,206 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 09, 2007 Filed Aug 10, 2007 23:21 UTC |
FREYMAN THOMAS CExecutive Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 24,839 | $0.00 Strike: $46.92 | $0.00 |
DisclosureSEC source: 0001104659-07-061521 · a4.xml · derivative · entry 11 FREYMAN THOMAS C · CIK 0001239126 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 24,839 shares Expires 2008-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| August 09, 2007 Filed Aug 10, 2007 23:21 UTC |
FREYMAN THOMAS CExecutive Vice President
|
Tax withholdingCommon shares without par value | 22,333 | $56.30 | $1,257,347.90 |
DisclosureSEC source: 0001104659-07-061521 · a4.xml · nonDerivative · entry 4 FREYMAN THOMAS C · CIK 0001239126 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 278,705 Read SEC document |
| August 09, 2007 Filed Aug 10, 2007 23:21 UTC |
FREYMAN THOMAS CExecutive Vice President
|
Exercise / conversionCommon shares without par value | 24,839 | $46.92 | $1,165,435.94 |
DisclosureSEC source: 0001104659-07-061521 · a4.xml · nonDerivative · entry 3 FREYMAN THOMAS C · CIK 0001239126 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 301,038 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 09, 2007 Filed Aug 13, 2007 21:07 UTC |
Landgraf John CSenior Vice President
|
GrantOption (right to buy) · Derivative | 8,421 | $0.00 Strike: $56.30 | $0.00 |
DisclosureSEC source: 0001104659-07-061937 · a4.xml · derivative · entry 7 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,421 Underlying: Common Shares · 8,421 shares Expires 2008-02-12 F5 · security: Employee stock option, including a replacement option, granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| August 09, 2007 Filed Aug 13, 2007 21:07 UTC |
Landgraf John CSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 9,738 | $0.00 Strike: $43.73 | $0.00 |
DisclosureSEC source: 0001104659-07-061937 · a4.xml · derivative · entry 6 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 9,738 shares Expires 2008-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: Employee stock option, including a replacement option, granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| August 09, 2007 Filed Aug 13, 2007 21:07 UTC |
Landgraf John CSenior Vice President
|
Tax withholdingCommon shares without par value | 8,421 | $56.30 | $474,102.30 |
DisclosureSEC source: 0001104659-07-061937 · a4.xml · nonDerivative · entry 2 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,444 Read SEC document |
| August 09, 2007 Filed Aug 13, 2007 21:07 UTC |
Landgraf John CSenior Vice President
|
Exercise / conversionCommon shares without par value | 9,738 | $43.73 | $425,842.74 |
DisclosureSEC source: 0001104659-07-061937 · a4.xml · nonDerivative · entry 1 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,865 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 09, 2007 Filed Aug 13, 2007 21:07 UTC |
LINDER GREG WVice President
|
GrantOption (right to buy) · Derivative | 1,775 | $0.00 Strike: $56.30 | $0.00 |
DisclosureSEC source: 0001104659-07-061939 · a4.xml · derivative · entry 16 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,775 Underlying: Common Shares · 1,775 shares Expires 2008-02-12 F2 · security: Employee stock option including a replacement option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| August 09, 2007 Filed Aug 13, 2007 21:07 UTC |
LINDER GREG WVice President
|
Exercise / conversionOption (right to buy) · Derivative | 2,875 | $0.00 Strike: $34.77 | $0.00 |
DisclosureSEC source: 0001104659-07-061939 · a4.xml · derivative · entry 15 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 2,875 shares Expires 2008-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option including a replacement option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| August 09, 2007 Filed Aug 13, 2007 21:07 UTC |
LINDER GREG WVice President
|
Exercise / conversionOption (right to buy) · Derivative | 12,000 | $0.00 Strike: $44.16 | $0.00 |
DisclosureSEC source: 0001104659-07-061939 · a4.xml · derivative · entry 14 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,000 Underlying: Common Shares · 12,000 shares Expires 2016-02-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| August 09, 2007 Filed Aug 13, 2007 21:07 UTC |
LINDER GREG WVice President
|
GrantOption (right to buy) · Derivative | 10,630 | $0.00 Strike: $56.30 | $0.00 |
DisclosureSEC source: 0001104659-07-061939 · a4.xml · derivative · entry 13 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,630 Underlying: Common Shares · 10,630 shares Expires 2013-02-13 F2 · security: Employee stock option including a replacement option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| August 09, 2007 Filed Aug 13, 2007 21:07 UTC |
LINDER GREG WVice President
|
Exercise / conversionOption (right to buy) · Derivative | 12,431 | $0.00 Strike: $42.83 | $0.00 |
DisclosureSEC source: 0001104659-07-061939 · a4.xml · derivative · entry 12 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 12,431 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option including a replacement option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| August 09, 2007 Filed Aug 13, 2007 21:07 UTC |
LINDER GREG WVice President
|
GrantOption (right to buy) · Derivative | 16,974 | $0.00 Strike: $56.30 | $0.00 |
DisclosureSEC source: 0001104659-07-061939 · a4.xml · derivative · entry 11 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,974 Underlying: Common Shares · 16,974 shares Expires 2009-05-31 F2 · security: Employee stock option including a replacement option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| August 09, 2007 Filed Aug 13, 2007 21:07 UTC |
LINDER GREG WVice President
|
Exercise / conversionOption (right to buy) · Derivative | 20,004 | $0.00 Strike: $42.22 | $0.00 |
DisclosureSEC source: 0001104659-07-061939 · a4.xml · derivative · entry 10 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 20,004 shares Expires 2009-05-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option including a replacement option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| August 09, 2007 Filed Aug 13, 2007 21:07 UTC |
LINDER GREG WVice President
|
GrantOption (right to buy) · Derivative | 8,143 | $0.00 Strike: $56.30 | $0.00 |
DisclosureSEC source: 0001104659-07-061939 · a4.xml · derivative · entry 9 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,143 Underlying: Common Shares · 8,143 shares Expires 2009-02-11 F2 · security: Employee stock option including a replacement option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| August 09, 2007 Filed Aug 13, 2007 21:07 UTC |
LINDER GREG WVice President
|
Exercise / conversionOption (right to buy) · Derivative | 9,563 | $0.00 Strike: $42.50 | $0.00 |
DisclosureSEC source: 0001104659-07-061939 · a4.xml · derivative · entry 8 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,353 Underlying: Common Shares · 9,563 shares Expires 2009-02-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option including a replacement option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| August 09, 2007 Filed Aug 13, 2007 21:07 UTC |
LINDER GREG WVice President
|
Tax withholdingCommon shares without par value | 47,955 | $56.30 | $2,699,866.50 |
DisclosureSEC source: 0001104659-07-061939 · a4.xml · nonDerivative · entry 6 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,113 Read SEC document |
| August 09, 2007 Filed Aug 13, 2007 21:07 UTC |
LINDER GREG WVice President
|
Exercise / conversionCommon shares without par value | 2,875 | $34.77 | $99,971.51 |
DisclosureSEC source: 0001104659-07-061939 · a4.xml · nonDerivative · entry 5 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 177,068 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 09, 2007 Filed Aug 13, 2007 21:07 UTC |
LINDER GREG WVice President
|
Exercise / conversionCommon shares without par value | 12,000 | $44.16 | $529,920.00 |
DisclosureSEC source: 0001104659-07-061939 · a4.xml · nonDerivative · entry 4 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 174,193 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 09, 2007 Filed Aug 13, 2007 21:07 UTC |
LINDER GREG WVice President
|
Exercise / conversionCommon shares without par value | 12,431 | $42.83 | $532,419.73 |
DisclosureSEC source: 0001104659-07-061939 · a4.xml · nonDerivative · entry 3 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 162,193 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 09, 2007 Filed Aug 13, 2007 21:07 UTC |
LINDER GREG WVice President
|
Exercise / conversionCommon shares without par value | 20,004 | $42.22 | $844,486.86 |
DisclosureSEC source: 0001104659-07-061939 · a4.xml · nonDerivative · entry 2 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 149,762 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 09, 2007 Filed Aug 13, 2007 21:07 UTC |
LINDER GREG WVice President
|
Exercise / conversionCommon shares without par value | 9,563 | $42.50 | $406,406.46 |
DisclosureSEC source: 0001104659-07-061939 · a4.xml · nonDerivative · entry 1 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,758 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 08, 2007 Filed Aug 9, 2007 21:06 UTC |
Chen Thomas FSenior Vice President
|
GrantOption (right to buy) · Derivative | 11,064 | $0.00 Strike: $54.30 | $0.00 |
DisclosureSEC source: 0001104659-07-061021 · a4.xml · derivative · entry 21 Chen Thomas F · CIK 0001360147 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,064 Underlying: common shares · 11,064 shares Expires 2009-02-11 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| August 08, 2007 Filed Aug 9, 2007 21:06 UTC |
Chen Thomas FSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 10,622 | $0.00 Strike: $42.50 | $0.00 |
DisclosureSEC source: 0001104659-07-061021 · a4.xml · derivative · entry 16 Chen Thomas F · CIK 0001360147 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,459 Underlying: common shares · 10,622 shares Expires 2009-02-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| August 08, 2007 Filed Aug 9, 2007 21:06 UTC |
Chen Thomas FSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 2,352 | $0.00 Strike: $42.50 | $0.00 |
DisclosureSEC source: 0001104659-07-061021 · a4.xml · derivative · entry 15 Chen Thomas F · CIK 0001360147 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 2,352 shares Expires 2009-02-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| August 08, 2007 Filed Aug 9, 2007 21:06 UTC |
Chen Thomas FSenior Vice President
|
Tax withholdingCommon shares without par value | 11,064 | $54.30 | $600,775.20 |
DisclosureSEC source: 0001104659-07-061021 · a4.xml · nonDerivative · entry 7 Chen Thomas F · CIK 0001360147 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,610 Read SEC document |
| August 08, 2007 Filed Aug 9, 2007 21:06 UTC |
Chen Thomas FSenior Vice President
|
Exercise / conversionCommon shares without par value | 12,974 | $42.50 | $551,366.46 |
DisclosureSEC source: 0001104659-07-061021 · a4.xml · nonDerivative · entry 6 Chen Thomas F · CIK 0001360147 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,674 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 08, 2007 Filed Aug 9, 2007 21:27 UTC |
Landgraf John CSenior Vice President
|
GrantOption (right to buy) · Derivative | 13,439 | $0.00 Strike: $54.30 | $0.00 |
DisclosureSEC source: 0001104659-07-061057 · a4.xml · derivative · entry 17 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,439 Underlying: Common shares · 13,439 shares Expires 2013-02-13 F6 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| August 08, 2007 Filed Aug 9, 2007 21:27 UTC |
Landgraf John CSenior Vice President
|
GrantOption (right to buy) · Derivative | 11,816 | $0.00 Strike: $54.30 | $0.00 |
DisclosureSEC source: 0001104659-07-061057 · a4.xml · derivative · entry 16 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,816 Underlying: Common shares · 11,816 shares Expires 2009-02-11 F5 · security: Employee stock option including a replacement option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| August 08, 2007 Filed Aug 9, 2007 21:27 UTC |
Landgraf John CSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 15,409 | $0.00 Strike: $42.83 | $0.00 |
DisclosureSEC source: 0001104659-07-061057 · a4.xml · derivative · entry 15 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 15,409 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| August 08, 2007 Filed Aug 9, 2007 21:27 UTC |
Landgraf John CSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 13,607 | $0.00 Strike: $42.50 | $0.00 |
DisclosureSEC source: 0001104659-07-061057 · a4.xml · derivative · entry 14 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,353 Underlying: Common shares · 13,607 shares Expires 2009-02-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: Employee stock option including a replacement option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| August 08, 2007 Filed Aug 9, 2007 21:27 UTC |
Landgraf John CSenior Vice President
|
Tax withholdingCommon shares without par value | 25,255 | $54.30 | $1,371,346.50 |
DisclosureSEC source: 0001104659-07-061057 · a4.xml · nonDerivative · entry 6 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,127 Read SEC document |
| August 08, 2007 Filed Aug 9, 2007 21:27 UTC |
Landgraf John CSenior Vice President
|
Exercise / conversionCommon shares without par value | 15,409 | $42.83 | $659,967.47 |
DisclosureSEC source: 0001104659-07-061057 · a4.xml · nonDerivative · entry 5 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,382 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 08, 2007 Filed Aug 9, 2007 21:27 UTC |
Landgraf John CSenior Vice President
|
Exercise / conversionCommon shares without par value | 13,607 | $42.50 | $578,267.56 |
DisclosureSEC source: 0001104659-07-061057 · a4.xml · nonDerivative · entry 4 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,973 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 08, 2007 Filed Aug 9, 2007 21:48 UTC |
DEMPSEY WILLIAM GExecutive Vice President
|
GrantOption (right to buy) · Derivative | 21,146 | $0.00 Strike: $54.30 | $0.00 |
DisclosureSEC source: 0001104659-07-061073 · a4.xml · derivative · entry 15 DEMPSEY WILLIAM G · CIK 0001239422 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,146 Underlying: Common shares · 21,146 shares Expires 2013-02-13 F2 · security: Employee stock option, including replacement option feature granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| August 08, 2007 Filed Aug 9, 2007 21:48 UTC |
DEMPSEY WILLIAM GExecutive Vice President
|
GrantOption (right to buy) · Derivative | 62,637 | $0.00 Strike: $54.30 | $0.00 |
DisclosureSEC source: 0001104659-07-061073 · a4.xml · derivative · entry 14 DEMPSEY WILLIAM G · CIK 0001239422 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,637 Underlying: Common shares · 62,637 shares Expires 2009-02-11 F2 · security: Employee stock option, including replacement option feature granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| August 08, 2007 Filed Aug 9, 2007 21:48 UTC |
DEMPSEY WILLIAM GExecutive Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 24,247 | $0.00 Strike: $42.83 | $0.00 |
DisclosureSEC source: 0001104659-07-061073 · a4.xml · derivative · entry 13 DEMPSEY WILLIAM G · CIK 0001239422 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,081 Underlying: Common shares · 24,247 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option, including replacement option feature granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| August 08, 2007 Filed Aug 9, 2007 21:48 UTC |
DEMPSEY WILLIAM GExecutive Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 72,130 | $0.00 Strike: $42.50 | $0.00 |
DisclosureSEC source: 0001104659-07-061073 · a4.xml · derivative · entry 12 DEMPSEY WILLIAM G · CIK 0001239422 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,353 Underlying: Common shares · 72,130 shares Expires 2009-02-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option, including replacement option feature granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| August 08, 2007 Filed Aug 9, 2007 21:48 UTC |
DEMPSEY WILLIAM GExecutive Vice President
|
Tax withholdingCommon shares without par value | 83,783 | $54.30 | $4,549,416.90 |
DisclosureSEC source: 0001104659-07-061073 · a4.xml · nonDerivative · entry 6 DEMPSEY WILLIAM G · CIK 0001239422 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 237,413 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.